Vanguard Group’s Calithera Biosciences, Inc CALA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $154K | Sell |
|
|||||
|
2022
Q3 | $415K | Buy |
|
|||||
|
2022
Q2 | $282K | Buy |
|
|||||
|
2022
Q1 | $863K | Sell |
|
|||||
|
2021
Q4 | $1.9M | Sell |
|
|||||
|
2021
Q3 | $6.4M | Sell |
|
|||||
|
2021
Q2 | $6.14M | Sell |
|
|||||
|
2021
Q1 | $8.96M | Buy |
|
|||||
|
2020
Q4 | $18M | Buy |
|
|||||
|
2020
Q3 | $12.3M | Buy |
|
|||||
|
2020
Q2 | $17.3M | Buy |
|
|||||
|
2020
Q1 | $10.9M | Buy |
|
|||||
|
2019
Q4 | $13.3M | Sell |
|
|||||
|
2019
Q3 | $7.2M | Buy |
|
|||||
|
2019
Q2 | $8.24M | Buy |
|
|||||
|
2019
Q1 | $10.8M | Buy |
|
|||||
|
2018
Q4 | $5.86M | Buy |
|
|||||
|
2018
Q3 | $6.78M | Buy |
|
|||||
|
2018
Q2 | $6.13M | Buy |
|
|||||
|
2018
Q1 | $7.42M | Buy |
|
|||||
|
2017
Q4 | $9.29M | Buy |
|
|||||
|
2017
Q3 | $17.3M | Sell |
|
|||||
|
2017
Q2 | $17.8M | Buy |
|
|||||
|
2017
Q1 | $10.7M | Buy |
|
|||||
|
2016
Q4 | $1.5M | Buy |
|
|||||
|
2016
Q3 | $1.36M | Sell |
|
|||||
|
2016
Q2 | $1.6M | Sell |
|
|||||
|
2016
Q1 | $2.54M | Buy |
|
|||||
|
2015
Q4 | $3.32M | Buy |
|
|||||
|
2015
Q3 | $2.32M | Buy |
|
|||||
|
2015
Q2 | $1.99M | Buy |
|
|||||
|
2015
Q1 | $4.32M | Buy |
|
|||||
|
2014
Q4 | $4.44M | Buy |
|